[go: up one dir, main page]

WO2006021335A3 - Peptidmischung aus peptiden mit einem molekulargewicht vom 1000-5000 dalton - Google Patents

Peptidmischung aus peptiden mit einem molekulargewicht vom 1000-5000 dalton Download PDF

Info

Publication number
WO2006021335A3
WO2006021335A3 PCT/EP2005/008805 EP2005008805W WO2006021335A3 WO 2006021335 A3 WO2006021335 A3 WO 2006021335A3 EP 2005008805 W EP2005008805 W EP 2005008805W WO 2006021335 A3 WO2006021335 A3 WO 2006021335A3
Authority
WO
WIPO (PCT)
Prior art keywords
peptide mixture
peptides
dalton
molecular weight
immune system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2005/008805
Other languages
English (en)
French (fr)
Other versions
WO2006021335A2 (de
Inventor
Guenther Boehm
Christopher Beermann
Gilda Georgi
Bernd Stahl
Joachim Schmitt
Nadine Bock
Soerge Kelm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutricia NV
Original Assignee
Nutricia NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia NV filed Critical Nutricia NV
Priority to US11/660,595 priority Critical patent/US20080096794A1/en
Priority to EP05777789A priority patent/EP1799053A2/de
Publication of WO2006021335A2 publication Critical patent/WO2006021335A2/de
Publication of WO2006021335A3 publication Critical patent/WO2006021335A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/346—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A23J3/344—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Die Erfindung betrifft die Verwendung einer Peptidmischung aus Peptiden mit einem Molekulargewicht von 1000 bis 5000 Dalton zur Prävention und/oder Behandlung von Tumorerkrankungen, von Erkrankungen, welche mit einer Entwicklungsstörung des Immunsystems assoziiert sind, von Erkrankungen des Immunsystems, von Autoimmunreaktionen, von Allergien und von Entzündungen beim Menschen, eine Proteinkomponente, welche eine derartige Peptidmischung enthält, und eine diese Peptidmischung enthaltene Formelnahrung. Die Peptide werden vorzugsweise aus für Nahrungszwecke geeigneten, nicht­humanen Proteinen erhalten, insbesondere durch die enzymatische oder hydrolytische Spaltung dieser Proteine.
PCT/EP2005/008805 2004-08-20 2005-08-12 Peptidmischung aus peptiden mit einem molekulargewicht vom 1000-5000 dalton Ceased WO2006021335A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US11/660,595 US20080096794A1 (en) 2004-08-20 2005-08-12 Peptide Mixture From Peptides Having A Molecular Weight Of from 1000 To 5000 Dalton
EP05777789A EP1799053A2 (de) 2004-08-20 2005-08-12 Peptidmischung aus peptiden mit einem molekulargewicht vom 1000-5000 dalton

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004040452A DE102004040452A1 (de) 2004-08-20 2004-08-20 Peptidgemisch
DE102004040452.6 2004-08-20

Publications (2)

Publication Number Publication Date
WO2006021335A2 WO2006021335A2 (de) 2006-03-02
WO2006021335A3 true WO2006021335A3 (de) 2006-04-20

Family

ID=35613806

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2005/008805 Ceased WO2006021335A2 (de) 2004-08-20 2005-08-12 Peptidmischung aus peptiden mit einem molekulargewicht vom 1000-5000 dalton

Country Status (5)

Country Link
US (1) US20080096794A1 (de)
EP (1) EP1799053A2 (de)
CN (1) CN101043900A (de)
DE (1) DE102004040452A1 (de)
WO (1) WO2006021335A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0621481A2 (pt) * 2006-03-23 2011-12-13 Nestec Sa suplemento nutricional de alta caloria
DE102008062136B4 (de) * 2008-12-16 2012-05-03 Kamamed Ug Pharmazeutische Zusammensetzung auf Basis von Peptid aus Kamelmilch
MY172020A (en) * 2009-03-04 2019-11-12 Nestec Sa Oligosaccharide ingredient
CA2773686C (en) * 2009-04-02 2018-01-16 Novozymes A/S Process for making a milk-based protein hydrolysate
PL2332428T3 (pl) * 2009-12-04 2015-02-27 Mjn Us Holdings Llc Formulacja odżywcza zawierająca hydrolizat zawierający peptydy mleka krowiego i/lub pochodzące z niego peptydy do indukowania tolerancji
CN103153095B (zh) * 2010-08-24 2015-07-22 雅培制药有限公司 具有改良感官特性的营养产品
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9352020B2 (en) * 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
CN110041424A (zh) * 2019-03-22 2019-07-23 新疆大学 一种驼乳乳清抗肿瘤活性蛋白及其制备方法和应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135592A1 (de) * 1983-02-02 1985-04-03 Kyowa Hakko Kogyo Co., Ltd. Dna-synthese verhindernde substanz
EP0626177A2 (de) * 1993-05-28 1994-11-30 Abbott Laboratories Nahrung für mit HIV infizierte Menschen
WO2004069265A1 (en) * 2003-02-07 2004-08-19 Campina B.V. Use of tryptophan rich peptides
WO2004113378A2 (en) * 2003-06-16 2004-12-29 Hannah Research Institute Control of lactation and peptides therefore

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229136A (en) * 1992-05-21 1993-07-20 Clintec Nutrition Co. Low caloric density enteral formulation designed to reduce diarrhea in tube-fed patients
US5472952A (en) * 1993-03-18 1995-12-05 Bristol-Myers Squibb Company Partially hydrolyzed pectin in nutritional compositions
US5330972A (en) * 1993-05-28 1994-07-19 Abbott Laboratories Method of impeding apoptosis of CD4 cells in persons infected with human immunodeficiency virus
US5906982A (en) * 1997-03-31 1999-05-25 Abbott Laboratories Nutritional formulations containing Lacto-N-neoTetraose
US6808736B2 (en) * 2001-06-07 2004-10-26 Nestec S.A. Soy hydrolysate based nutritional formulations
US7867541B2 (en) * 2003-04-14 2011-01-11 Mead Johnson Nutrition Company Compositions and methods of formulation for enteral formulas containing sialic acid

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135592A1 (de) * 1983-02-02 1985-04-03 Kyowa Hakko Kogyo Co., Ltd. Dna-synthese verhindernde substanz
EP0626177A2 (de) * 1993-05-28 1994-11-30 Abbott Laboratories Nahrung für mit HIV infizierte Menschen
WO2004069265A1 (en) * 2003-02-07 2004-08-19 Campina B.V. Use of tryptophan rich peptides
WO2004113378A2 (en) * 2003-06-16 2004-12-29 Hannah Research Institute Control of lactation and peptides therefore

Also Published As

Publication number Publication date
CN101043900A (zh) 2007-09-26
DE102004040452A1 (de) 2006-02-23
WO2006021335A2 (de) 2006-03-02
EP1799053A2 (de) 2007-06-27
US20080096794A1 (en) 2008-04-24

Similar Documents

Publication Publication Date Title
WO2006021335A3 (de) Peptidmischung aus peptiden mit einem molekulargewicht vom 1000-5000 dalton
Escudero et al. Angiotensin I-converting enzyme inhibitory peptides generated from in vitro gastrointestinal digestion of pork meat
WO2004078777A3 (en) Dipeptidyl-peptidase protected proteins
WO2005019258A3 (en) Compositions and methods for the treatment of immune related diseases
WO2004043361A3 (en) Compositions and methods for the treatment of natural killer cell related diseases
WO2004047728A3 (en) Compositions and methods for the treatment of immune related diseases
WO2004039956A3 (en) Compositions and methods for the treatment of immune related diseases
DK1898724T3 (da) Spædbarnsernæring med hydrolyserede proteiner
WO2012006384A3 (en) Rothia species gluten-degrading enzymes and uses thereof
GB9801420D0 (en) Frozen food product
ATE388166T1 (de) Bioaktive peptide, die durch enzymatische hydrolyse aus den proteinen von eiweiss gewonnen werden
WO2006034172A3 (en) GLYCININ-RICH AND β-CONGLYCININ-RICH VEGETABLE PROTEIN FRACTIONS
WO2004098536A3 (en) Anti-viral activity of cathelicidin peptides
WO2006052821A3 (en) Compositions and methods for treatment of protein misfolding and protein aggregation diseases
AU6228300A (en) Modification of foaming properties of proteins
WO2004024072A3 (en) Novel compositions and methods for the treatment of immune related diseases
WO2005000862A3 (en) Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
WO2002046211A3 (en) Peptides derived from colostrinin
WO2003004517A3 (en) Peyers's patch and/or m-celle targeting ligands
WO2001007479A3 (en) Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases
WO2006028561A3 (en) Novel purified fabi polypeptides from fransicella tularensis
WO2007087053A3 (en) Bmp-7 variant compositions, methods and uses
WO2009083968A8 (en) Novel protein
WO2003025014A3 (fr) Utilisation de peptides comportant des modifications de type post-traductionnel dans le cadre du traitement de pathologies auto-immunes
Naknukool et al. Multiple biological functions of novel basic proteins isolated from duck egg white: duck basic protein small 1 (dBPS1) and 2 (dBPS2)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2005777789

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 11660595

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 200580035838.3

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 2005777789

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 11660595

Country of ref document: US